
May 17, 2021: Astellas to Present Data from Expanding Oncology Portfolio During the 2021 ASCO Annual Meeting May 26, 2021: Astellas announces new corporate strategic plan 2021 Jun 02, 2021: Astellas updates EHS (Environment, Health and Safety) Website Jun 03, 2021: Astellas Pharma: Reviewing capabilities for sustainable growth Astellas is headquartered in Tokyo, Japan.Īstellas Pharma Inc Key Recent Developments It operates in the Americas Europe and Asia and Oceania through its network of subsidiaries and affiliates. It is investigating its pipeline encompasses candidates for the treatment of urothelial cancer gastric cancer gastroesophageal junction cancer anemia associated with chronic kidney disease (CKD) in dialysis and non-dialysis patients menopause-related vasomotor symptoms (MR-VMS) such as hot flashes and night sweats and acute myeloid leukemia (AML), among others. The company’s product portfolio comprises marketed products for the treatment of a wide range of urological diseases, infectious diseases, cancer, nephrology, and metabolic diseases, immunodeficiency diseases, and transplantation.



The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats.
Astellas pdf info registration#
If you opt-out your email will still be collected for registration purposes.Astellas Pharma Inc (4503) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform.

By accessing or using the AdisInsight platform you agree to the terms of use.
